Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
LNSR
SellFallen FavouriteLENSAR, Inc. · Healthcare · United States · $102M · Avg Vol: $1M/d
22
StockRankGet insider-trade alerts
Q
54
V
29
M
24
P/E (TTM)
42.9x
ROE
357.3%
D/E
0.1x
Dividend %
—
COMPANY DESCRIPTION
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 35.4M | 42.2M | 53.5M | 58.4M | 18.2% | 60.3M | 61.3M | 73.9M | 12.5% |
| EPS | -1.96 | -1.31 | -2.73 | -2.87 | — | 0.20 | — | — | — |
| Shares | 11.1M | 11.3M | 11.7M | 12.0M | +8.1% | 12.3M | — | — | — |
| Debt | 2.8M | 2.3M | 2.6M | 2.7M | -0.8% | 2.4M | — | — | — |
| Equity | 42.0M | 33.4M | 4.9M | -26.0M | -66.0% | — | — | — | — |
| Op CF | -14.9M | -9.7M | -2.3M | -14.8M | — | -7.3M | — | — | — |
| Inv CF | -0.1M | -4.2M | -2.2M | 1.3M | — | — | — | — | — |
| Fin CF | -2.0M | 19.8M | 78.0K | 10.3M | — | — | — | — | — |
Loading 1Y...
PRICE (1Y)+58.3%
SMA 50SMA 200
Close
$8.31
RSI (14)
43.4
52W High
$12.94
From 52W High
0.6%
SCORE BREAKDOWN
Quality
54
ROIC
-53.6%14.6
ROE
357.3%99.9
GP/Assets
40.8%78.7
Op. Margin
12.9%69.9
FCF/Assets
-20.9%20.3
Piotroski
316.1
Int. Cover
—89.2
D/E Ratio
0.08x64.6
Current Ratio
2.39x46.6
Value
29
P/E (TTM)
42.9x25.9
EV/EBITDA
-6.4x25.0
P/FCF
—N/A
P/B
7.1x18.7
P/S
1.7x72.3
Div Yield
—N/A
Momentum
24
52W High %
64%41.1
RS 6M
-42%18.2
SMA 50/200
0.82x18.4
EPS Rev 4W
0.0%34.5
EPS Rev 12W
—N/A
EPS Improve
-455%1.1
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$102M
P/E (Forward)
-12.1x
Gross Margin
48.3%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of LNSR are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| LNSR | LENSAR, Inc.(you) | $102M | 22 | Sell |
| LUNG | Pulmonx Corporation | $102M | 29 | Sell |
| OM | Outset Medical, Inc. | $74M | 24 | Sell |
| APYX | Apyx Medical Corporation | $130M | 18 | Strong Sell |
| SRTS | Sensus Healthcare, Inc. | $58M | 22 | Sell |
| QTRX | Quanterix Corporation | $125M | 14 | Strong Sell |
| SERA | Sera Prognostics, Inc. | $82M | 14 | Strong Sell |
| HYPR | Hyperfine, Inc. | $88M | 12 | Strong Sell |
| ECOR | electroCore, Inc. | $87M | 32 | Sell |
| OWLT | Owlet, Inc. | $146M | 15 | Strong Sell |
Peer medians: ROE -30.8% · P/E 26.9x · Gross margin 58.3%